Your selections:
Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: the ELSIE Study
- Lim, Robert, Sun, Yan, Im, Seock-Ah, Hsieh, Ruey-Kuen, Yau, Tsz Kok, Bonaventura, Anthony, Cheirsilpa, Arkom, Esser, Regina, Mueser, Matthias, Advani, Suresh
- Tebbutt, Niall C., Wilson, Kate, Forgeson, Garry, Cunningham, David, Saunders, Mark P., Stockler, Martin R., Chua, Yujo, Zalcberg, John R., Simes, R. John, Price, Timothy J., Gebski, Val J., Cummins, Michelle M., Zannino, Dianna, van Hazel, Guy A., Robinson, Bridget, Broad, Adam, Ganju, Vinod, Ackland, Stephen P.
Are you sure you would like to clear your session, including search history and login status?